{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fdaily-kanaal-z.simplecast.com%2Fepisodes%2Fz-beurs-dinsdag-23-09-25-met-danny-reweghs-OcQw9ZHS","width":444,"version":"1.0","type":"rich","title":"Z-Beurs dinsdag 23/09/25 met Danny Reweghs","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/84dde845-cc6a-411d-b15f-831ee81d5497/e00249ad-e332-41b7-88f4-01b26f655973/tr-podcast7-7-nl.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/9cdc4683-062b-439e-b0c8-576d78c26c84\" height=\"200\" width=\"100%\" title=\"Z-Beurs dinsdag 23/09/25 met Danny Reweghs\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"We bespreken met huisanalist Danny Reweghs de toetreding van Argenx tot de Euro Stoxx 50, het elite-kransje van de Europese beurswereld. En farmareus Pfizer koopt zich toegang tot de felbegeerde markt van de afslankmiddelen, met de miljardenovername van Metsera. "}